Open Call: Apply for TRANSVAC2 Vaccine Development Services

Open Call: Apply for TRANSVAC2 Vaccine Development Services Developing a vaccine is a time-consuming and complex process, requiring a combination of specialized skills and technical capacities not readily available at...

Pre-print publication COVID19

PRE-PRINT COVID19 : Discovery of clinically approved drugs capable of inhibiting SARS-CoV-2 in vitro infection using a phenotypic screening strategy and network-analysis to predict their potential to treat covid-19 Authors:...

BIOASTER & GENCOVERY

BIOASTER first shareholder with its two co-founders Adama OUATTARA and Wassim ABOU-JAOUDE of Gencovery. Wishing success to the first BIOASTER start-up. Gencovery provides cutting-edge software based on digital organisms for...
Post archive